Evaluation and Modeling with the Therapeutic Effects Group
Members
Stagiaire
UCBL

Maîtresse de conférences - praticienne hospitalière
UCBL
Tel: 04 72 11 94 07
Maître de conférences - praticien hospitalier
UCBL
Tel: 33 04 72 32 34 87

Professeur des universités - médecin généraliste
UCBL
Tel: 04 78 74 18 18

Maîtresse de conférences
UCBL
Tel: 33 04 78 78 57 83

Professeure des universités - médecin généraliste
UCBL
Tel: 04 78 77 72 86

Professeur d'université - praticien hospitalier
UCBL
Tel: 04 72 44 81 42
Doctorante
HCL
Assistant hospitalier universitaire
UCBL
Doctorant
UCBL
Tel: 04 72 44 81 42

Professeur d'université - praticien hospitalier
UCBL
Tel: 33 04 72 16 80 99

Doctorante
autre
Tel: 04 72 44 81 42

Praticien hospitalier
HCL
Tel: 04 72 44 81 42

Professeur d'université - praticien hospitalier émérite
UCBL

Professeur d'université - praticien hospitalier
UCBL
Tel: 04 27 85 77 32

Professeur d'université - praticien hospitalier
UCBL
Tel: 33 04 78 86 33 01

Post-doc
UCBL

Maîtresse de conférences - praticienne hospitalière
UCBL
Maître de conférences - praticien hospitalier
UCBL
Tel: 04 72 11 94 20

Professeur d'université - praticien hospitalier
UCBL
Tel: 33 04 72 12 94 37
Post-doc
UCBL
Doctorante
UCBL
Tel: 04 72 44 81 42
Doctorante
HCL
EMET presentation
The EMET team brings together doctors, pharmacists and research professors specializing in the evaluation and use of drug and non-drug therapies, around a single project built on two axes:
- the evaluation of therapies in clinical trials or observational studies;
- the construction of explanatory and predictive models, to better understand and therefore predict the effect of therapies, simulate their impacts at the individual and population level, and improve the innovation paradigm.
The EMET team is therefore part of two major dynamics in therapy: analysis of the level of evidence and precision medicine.
The fields of application are cardiovascular and metabolic diseases, primary care medicine, rare pediatric diseases (including genetic and autoimmune diseases), oncology and infectious diseases.
EMET members implement approaches using different mathematical models: direct comparison and network meta-analysis, pharmacokinetic/pharmacodynamic analysis, Bayesian networks and machine learning.
Education
The EMET team is specially involved in the teaching of pharmacology and therapeutics and the modeling of the treatment effect through the coordination of the Masters 2 Clinical Evaluation (EC) and Pharmacology modeling and clinical trials (PHAME), Interpretation of Therapeutic Trials (IET), Training of investigators in clinical drug trials (FIEC) and Training of clinical research assistants and clinical study technicians (FARCTEC). Teacher-researchers are also involved in the first (pharmacology), second (pharmacology / therapeutics, pharmacy) and third cycles (general medicine, pediatrics, internal medicine) in health training courses.
Society involvement
The members of the EMET team through their work and their interactions with the other components of the LBBE, National societies, governmental (HAS) or international (EMA) agencies, and the Hospices Civils de Lyon, are invested in current societal issues: rationalization of the use of health product resources, research ethics, gender equality, rationality of approaches in analyzing the diversity of human populations.
Publications
Display of 91 to 120 publications on 626 in total
Intravenous Immunoglobulins Tapering and Withdrawal in Systemic Capillary Leak Syndrome (Clarkson Disease)
Journal of Allergy and Clinical Immunology: In Practice . 10 ( 11 ) : 2889-2895
Journal article
see the publicationThe consequences of COVID-19 pandemic on patients with monoclonal gammopathy–associated systemic capillary leak syndrome (Clarkson disease)
Journal of Allergy and Clinical Immunology: In Practice . 10 ( 2 ) : 626-629
Journal article
see the publicationQuelle place pour l’automatisation intelligente et l’intelligence artificielle pour préserver et renforcer l’expertise en vigilance devant l’augmentation des déclarations ?
Therapies . 78 ( 1 ) : 115-129
Journal article
see the publicationEstimating individualized treatment effects using individual participant data meta-analysis
Preprint
see the publicationA randomized controlled phase III study comparing hadrontherapy with carbon ions versus conventional radiotherapy – including photon and proton therapy – for the treatment of radioresistant tumors: the ETOILE trial
BMC Cancer . 22 ( 1 ) : 575
Journal article
see the publicationMachine-Learning Exploration of Exposure-Effect Relationships of Cisplatin in Head and Neck Cancer Patients
Pharmaceutics . 14 ( 11 ) : 2509
Journal article
see the publicationSGLT2 inhibitors in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials balancing their risks and benefits
Diabetologia . 65 : 2000-2010
Journal article
see the publicationIndirect Comparison of Glucocorticoid-Sparing Agents for Remission Maintenance in Giant Cell Arteritis: A Network Meta-analysis
Mayo Clinic Proceedings . 97 ( 10 ) : 1824-1835
Journal article
see the publicationScreening for hypertension-mediated organ damage and aetiology: still of value after 65 years of age?
Journal of Geriatric Cardiology . 19 ( 11 ) : 791-801
Journal article
see the publicationIntravenous Immunoglobulins Tapering and Withdrawal in Systemic Capillary Leak Syndrome (Clarkson Disease)
Journal of Allergy and Clinical Immunology: In Practice . 10 ( 11 ) : 2889-2895
Journal article
see the publicationRéponse sérologique après vaccination contre le coronavirus chez les patients atteints de rhumatisme inflammatoire chronique traités par DMARDs : étude de cohorte et revue systématique avec méta-analyse
Revue du Rhumatisme . 89 ( 5 ) : 435-446
Journal article
see the publicationImmune thrombocytopenia with clinical significance in systemic lupus erythematosus: a retrospective cohort study of 90 patients
Rheumatology . 61 ( 9 ) : 3627-3639
Journal article
see the publicationAssessment of Clinical Worsening End Points as a Surrogate for Mortality in Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Circulation . 146 ( 8 ) : 597-612
Journal article
see the publicationEffective Anti–SARS-CoV-2 Immune Response in Patients With Clonal Mast Cell Disorders
Journal of Allergy and Clinical Immunology: In Practice . 10 ( 5 ) : 1356-1364.e2
Journal article
see the publicationNécessité d’améliorer nos connaissances sur les pneumopathies interstitielles diffuses associées aux connectivites
Revue du Rhumatisme .
Journal article
see the publicationOff-label use of biologics for the treatment of refractory and/or relapsing granulomatosis with polyangiitis
European Journal of Internal Medicine . 96 : 97-101
Journal article
see the publicationVEXAS syndrome-related AA amyloidosis: a case report
Rheumatology . 61 ( 1 ) : e15-e16
Journal article
see the publicationEpidemiology of major relapse in giant cell arteritis: A study-level meta-analysis
Autoimmunity Reviews . 21 ( 1 ) : 102930
Journal article
see the publicationCryoglobulinemia in systemic lupus erythematosus: a retrospective study of 213 patients
Arthritis Research and Therapy . 24 ( 1 ) : 167
Journal article
see the publicationThe consequences of COVID-19 pandemic on patients with monoclonal gammopathy–associated systemic capillary leak syndrome (Clarkson disease)
Journal of Allergy and Clinical Immunology: In Practice . 10 ( 2 ) : 626-629
Journal article
see the publicationIntravenous Immunoglobulins Tapering and Withdrawal in Systemic Capillary Leak Syndrome (Clarkson Disease)
Journal of Allergy and Clinical Immunology: In Practice . 10 ( 11 ) : 2889-2895
Journal article
see the publicationInfection Risk in Patients with Dermatomyositis Associated with Anti-MDA5 Antibodies: A Historical Cohort Study
Biomedicines . 10 ( 12 ) : 3176
Journal article
see the publicationHuman Papilloma Virus Vaccination in Patients with Rheumatic Diseases in France: A Study of Vaccination Coverage and Drivers of Vaccination
Journal of Clinical Medicine . 11 ( 14 ) : 4137
DOI: 10.3390/jcm11144137
Journal article
see the publicationA call for evidence in connective tissue diseases-associated interstitial lung disease
Joint Bone Spine . 89 ( 1 ) : 105274
Journal article
see the publicationPublication bias in pharmacogenetics of adverse reaction to antiseizure drugs: An umbrella review and a meta-epidemiological study
PLoS ONE . 17 ( 12 ) : e0278839
Journal article
see the publicationCefepime Precision Dosing Tool: from Standard to Precise Dose Using Nonparametric Population Pharmacokinetics
Antimicrobial Agents and Chemotherapy . 66 ( 2 ) : e0204621
DOI: 10.1128/AAC.02046-21
Journal article
see the publicationAmikacin in emergency surgery: How to dose it optimally?
Anaesthesia Critical Care & Pain Medicine . 41 ( 1 ) : 100990
Journal article
see the publicationImplementation and Cross-Validation of a Pharmacokinetic Model for Precision Dosing of Busulfan in Hematopoietic Stem Cell Transplanted Children
Pharmaceutics . 14 ( 10 ) : 2107
Journal article
see the publicationPharmacokinetic/Pharmacodynamic Simulations of Cost-Effective Dosage Regimens of Ceftolozane-Tazobactam and Ceftazidime-Avibactam in Patients with Renal Impairment
Antimicrobial Agents and Chemotherapy . 66 ( 3 ) : e0210421
DOI: 10.1128/AAC.02104-21
Journal article
see the publicationImplementation assessment of a patient personalized clinical pharmacy programme (5P project) into orthogeriatric care pathway
Journal of Clinical Pharmacy and Therapeutics . 47 ( 7 ) : 956-963
DOI: 10.1111/jcpt.13627
Journal article
see the publication
You also, comment on this article